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ABSTRACT
The focus of this review is to highlight the need for improved communication between medical and
dental professionals in order to deliver more effective care to patients. The need for communication is
increasingly required to capitalise on recent advances in the biological sciences and in medicine for the
management of patients with chronic diseases. Improvements in longevity have resulted in populations
with increasing special oral-care needs, including those who have cancer of the head and neck, those
who are immunocompromised due to HIV ⁄AIDS, advanced age, residence in long-term care facilities or
the presence of life-long conditions, and those who are receiving long-term prescription medications for
chronic conditions (e.g., anti-hypertensives, anticoagulants, immunosuppressants, antidepressants).
These medications can cause adverse reactions in the oral cavity, such as xerostomia and ulceration.
Patients with xerostomia are at increased risk of tooth decay, periodontal disease and infection. The
ideal management of such individuals should involve the collaborative efforts of physicians, nurses,
dentists and dental hygienists, thus optimising treatment and minimising secondary complications
deriving from the oral cavity.
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INTRODUCTION
The oral cavity provides a variety of surfaces for
bacterial colonisation, and each environment sup-
ports a characteristic bacterial population. The
composition and quantity of the bacterial popu-
lation on mucosal and tooth surfaces are inﬂu-
enced by many factors, such as the integrity of the
soft-tissues, oral hygiene, saliva, diet, and the
host’s immune and inﬂammatory responses.
Numerous examples illustrate the devastating
effect that immunosuppression, radiation therapy
and medications can have on the oral tissues.
Systemic spread of oral microbes and spread
following immune responses may have deleteri-
ous consequences for systemic diseases and their
treatment. There is also increasing evidence that
periodontal disease may be associated with an
increased risk of cardiovascular disease, prema-
ture, low-birth-weight babies and respiratory
diseases. As the life-expectancy of the population
increases, in part due to advances in medical
science, it is highly recommended that the med-
ical and dental professions integrate their care of
patients.
UNDIAGNOSED MEDICAL
CONDITIONS
In 2005, Glick and Greenberg [1] evaluated the
possibility of dentists identifying patients with
risk-factors for cardiovascular disease prior to the
appearance of clinical signs and symptoms. They
examined surveys that had evaluated the health
and nutrition of Americans, aged 40–85 years,
between the years 1999 and 2000, and compared
the results with data from 2001–2002. They found
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that 18% of the men presented with a large
number of risk-factors for coronary artery disease.
Although still controversial, it has been suggested
that panoramic radiographs of the jaws can
capture images of calciﬁed carotid atheromas in
asymptomatic patients receiving routine dental
care [2]. Individuals visit the dentist more fre-
quently than they visit a medical practitioner, and
consequently the dentist is in a privileged posi-
tion to identify individuals at risk for cardiovas-
cular diseases, cancer, diabetes and hypertension,
and thus has an important role in the prevention
of infective endocarditis [3–5]. Therefore, collab-
orations between these healthcare professionals
would result in the early referral of patients,
leading to early diagnosis and prompt manage-
ment of emerging medical conditions.
ORAL HEALTH AND CANCER
THERAPY
All types of cancer treatment may predispose to
oral complications, and it is important that
patients undergoing chemotherapy, radiation
therapy (RT) and bone marrow transplantation
receive advice from a trained dental professional
prior to treatment. Such treatments are frequently
associated with oral complications that impact on
the quality of life and the cost of care. Dry mouth,
gingival bleeding, mucositis and ulceration all
contribute to the discomfort of patients and
interfere with daily activities such as eating and
talking. Oral complications may delay cancer
treatment and may be dose-limiting, thus inﬂu-
encing the outcome. These issues have prompted
the publication of guidelines for the prevention
and management of oral complications associated
with the treatment of cancer (http://www.
cancer.gov/cancertopics/pdq/supportivecare/oral
complications/HealthProfessional/page 3).
For example, patients diagnosed with head and
neck cancers who are scheduled for RT should be
referred to a dentist for assessment. Unfortu-
nately, in our experience, oncologists rarely for-
ward information regarding the type of tumour,
its location, the amount and timing of radiation
and the region of the head and neck to be
irradiated. Knowledge of the type of technique
chosen for radiotherapy (conventional, conforma-
tional, intensity-modulated radiotherapy or
tomotherapy) can help the dentist to anticipate
complications involving sensitive structures such
as salivary glands. This information is vital for the
design of a preventive dental programme [6,7].
However, general dentists are usually not fully
trained to evaluate oncology patients with respect
to potential head and neck complications antici-
pated during RT for cancer of the head and neck.
This lack of communication and training often
results in inadequate preparation of the oral
cavity. Consequently, secondary complications,
which include infections with opportunistic
organisms and the development of osteoradione-
crosis, may occur if untreated oral conditions
require subsequent manipulations of irradiated
areas [7].
Collaboration between an oral medicine spe-
cialist and the oncology team can signiﬁcantly
beneﬁt patients, and should include an initial
evaluation prior to treatment and regular follow-
up during the operative and post-operative peri-
ods. In the pre-operative phase, patients should
be advised of the importance and beneﬁts of
maintaining good oral hygiene, including a high-
ﬂuoride regimen for caries prevention, and
should receive dietary advice [8]. During the
period of therapy, the oral cavity should be
inspected frequently. The development of xero-
stomia and oral mucositis predisposes the patient
to extensive ulceration and injury of the mucosal
tissues, and increases the opportunity for oral
bacteria to gain access to the bloodstream and
cause infections at distant sites [9]. The course of
mucositis parallels that of bone marrow suppres-
sion induced by cancer therapy and increases the
risk of oral infection due to opportunistic micro-
organisms of bacterial, viral and fungal origin
[10,11]. A prompt diagnosis of these complica-
tions is vital for oral health, continuation of the
scheduled cancer therapy, and the overall success
of the treatment (Fig. 1).
BISPHOSPHONATE-ASSOCIATED
OSTEONECROSIS (BON)
Bisphosphonate-associated osteonecrosis of the
maxilla and mandible represents the most recent
example of the need for collaboration between
medical and dental professionals. This recently
described condition should lead to the building of
multidisciplinary medical teams including oncol-
ogists, specialists in bone diseases, maxillo-facial
surgeons, primary care physicians and specialists
in oral medicine [12]. Effects in the mouth
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represent one of the ﬁrst long-term complications
observed with bisphosphonate therapy [13]. Bis-
phosphonates are osteoclast inhibitors used in the
treatment of patients with osteopenia, osteoporo-
sis, hypercalcaemia of malignancy, Paget’s dis-
ease of bone, and cancer patients with bone
metastasis. This condition (BON) is deﬁned as
the unexpected development of necrotic bone in
the oral cavity of patients who are being treated
with a bisphosphonate and who have not re-
ceived RT to the head and neck (Fig. 2). When the
affected area persists for 6–8 weeks after proper
dental care is provided to the patient, the diag-
nosis of BON can be conﬁrmed [13]. On the basis
of the cases currently reported, the treatment of
cancer patients with nitrogen containing intrave-
nous bisphosphonate seems to present the highest
risk for this oral complication [13–16]. Other risk-
factors that have been implicated include the
presence of infection, recent dental extraction and
any oral surgical procedures where bone expo-
sure and ⁄ or manipulation occur. It has also been
suggested that the duration of drug exposure and
the number of bisphosphonate treatments are
important risk-factors for BON. Current guide-
lines, which are based on expert opinion, strongly
recommend that patients should be referred for
oral and dental evaluation prior to bisphospho-
nate therapy, thus providing the dental profes-
sional with the opportunity to diagnose and treat
any existing dental disease and recommend an
effective oral hygiene programme [14].
Infections are commonly reported in almost all
cases of exposed necrotic bone associated with
bisphosphonate therapy. The ﬂora recovered
from the sites contains both Gram-positive and
Gram-negative bacteria. Speciﬁc therapy with
antibiotics following culture and antibiogram
does not necessarily control the infection or
stimulate healing of the necrotic area. Several
reports describe the presence of Actinomyces spp.
and suggest a possible involvement of this organ-
ism in the aetiology of BON [17].
Information about the nature, duration and
detailed indications of the treatment is needed.
Long-term bisphosphonate therapy calls for
a reduction in and signiﬁcant alteration of
dental treatment plans in order to avoid surgical
(a) (b)
Fig. 1. A patient with lymphoma receiving high-dose chemotherapy complained of severe pain and bleeding in the oral
cavity. Maintenance of cancer therapy is vital for the control of the disease, and could not be discontinued at this time.
(a) The referral of the patient to an oral medicine specialist prompted a rapid diagnosis of Pseudomonas aeruginosa infection.
Speciﬁc antibiotic sensitivity testing led to the recommendation of a clindamycin and ciproﬂoxacin combination. Oral
hygiene included mouth rinses with chlorhexidine and iodine in an alternate schedule. (b) Three weeks after diagnosis, the
oral tissues were completely healed and the oral function was normal. The cancer therapy continued throughout the
management of the oral infection and did not have to be modiﬁed or stopped.
Fig. 2. A patient with cancer using zoledronic acid devel-
oped this area of exposed and necrotic bone in the oral
tissues. The area was infected, swollen and painful,
requiring antibiotic therapy and local debridement.
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manipulations that favour bone exposition, e.g.,
open periodontal curettage and implant place-
ment [15]. The dentist will need to be aware of
the life-expectancy of the patient according to the
oncologist, in order to adjust the objectives of the
dental programme to the patient’s individual risk
as related to the duration of drug exposure [18].
Patients can be educated and encouraged to
report to either the physician or the dentist when
oral complications are observed.
The development of optimal management strat-
egies for patients with BON, including discontin-
uation of therapy, is dependent on the
collaborative efforts of physicians, maxillo-facial
surgeons and dentists. However, since bisphos-
phonates are prescribed for medical reasons, it is
the physician who should make treatment
decisions, including discontinuation. Careful
assessment is required prior to discontinuation of
bisphosphonate therapy, as discontinuation can
lead to severe complications for some patients,
with additional risks noted among those with
osteoporosis. For example, hip fracture and high
mortality have been reported after cessation of an
oral bisphosphonate among such patients. The
reported incidence of death 1 year after hip
fracture is 20–25% [19]. These factors highlight
the need for consultations between the dentist
and physician for appropriate alternative treat-
ments [16].
ORAL HEALTH IN INTENSIVE CARE
UNITS
How can oral care be implemented in an envi-
ronment where the main objective is to preserve
the life of the patient? Effective oral hygiene keeps
the mouth functional and comfortable and, more
importantly, reduces the risk of local and systemic
infection [20]. Nurses often lack training in the
recognition of oral complications and the optimal
techniques for oral care [21]. In fact, it is very
difﬁcult to maintain oral care when the patient
has an endotracheal tube that, if displaced, can
result in a life-threatening situation [20]. Within
48–72 h, the oropharyngeal ﬂora, which is usually
dominated by Gram-positive bacteria, mainly
streptococci, shifts to a more pathogenic aerobic
Gram-negative ﬂora. When an endotracheal tube
is in place, the open-mouth position of the patient
results in xerostomia, an environment ideal for
bacterial colonisation and proliferation (Fig. 3). In
45% of critically ill patients, and 75–100% of
patients receiving ventilation, the upper respira-
tory tract is colonised by Gram-negative bacteria.
The average incidence of ventilator-associated
pneumonia is 47% of infections in patients in
intensive care units, with a mortality of 24–76%
[22,23]. A high percentage of patients with ven-
tilator-associated pneumonia have a Gram-nega-
tive ﬂora (including Pseudomonas aeruginosa,
Enterobacteriaceae, Haemophilus spp. and Acinet-
obacter spp.) and Gram-positive ﬂora (including
Staphylococcus aureus and Streptococcus spp.,
including Streptococcus pneumoniae) [22]. It is
important to maintain an effective programme
of oral hygiene, and studies have demonstrated
that chlorhexidine reduces the incidence of ven-
tilator-associated pneumonia and the colonisation
of the oropharynx by pathogenic ﬂora [23].
Several other oral hygiene programmes have been
tested, with the dual objective of improving oral
health and patient comfort and decreasing the
risk of local and systemic complications. Guide-
lines for nurses, issued by the CDC, stress the
importance of oral hygiene in intensive care unit
patients [24]. However, recent surveys in the USA
and Europe demonstrate that current practices are
far from effective, and training of medical ⁄dental
professionals in this ﬁeld of medicine is essential
[25–27].
Fig. 3. A patient in the intensive care unit. Observe that
the endotracheal tube prevents the patient from closing the
mouth, leading to xerostomia. The dry mouth is exacer-
bated by the action of several medications used in the
medical care of the patient. Maintaining good oral hygiene,
although very important, is difﬁcult, due to the mechanical
barriers, lack of patient cooperation, lack of training of
nurses, and the risk of displacing the tube. This favours
the colonisation of the oral tissues with pathogenic
microorganisms, increasing the risk of local and systemic
infections.
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ORAL HEALTH IN LONG-TERM-CARE
FACILITIES
The increasing elderly population [28] imposes
demands on medical care, with factors such as
frailty and loss of mobility making it difﬁcult for
these individuals to lead independent lives. Insti-
tutionalised care in long-term-care facilities and
nursing homes is becoming commonplace; such
facilities are typically supervised by physicians
and nurses, and rarely are dental professionals
involved. Consequently, oral care is provided by
non-dental personnel who have little or no train-
ing. Poor oral health in the elderly population
contributes to increased morbidity and decreased
quality of life [29].
Many of the prescription medications used by
elderly individuals are associated with the devel-
opment of dry mouth, which increases the risk of
colonisation of the oral mucosa by pathogenic
microorganisms that can cause both local and
systemic infections [28,29]. Deteriorating general
health and the long-term use of antibiotics in
nursing home residents lead to an increased
incidence of opportunistic infections such as
pneumonia, a signiﬁcant cause of morbidity and
mortality in the elderly [30]. The aspiration of oral
bacteria by institutionalised elderly individuals is
a risk-factor for hospital-acquired pneumonia
[30]. Several factors predispose this population
to changes in the oral environment. These factors
include poor oral hygiene, reduced dexterity,
poor compliance, and a neglected dentition, the
last of these making it difﬁcult for individuals to
chew and swallow with reasonable efﬁcacy. Pro-
fessionally delivered oral care could improve the
oral and general health of this population. Oral
hygiene performed professionally, even once a
week, can signiﬁcantly reduce the incidence of
aspiration pneumonia, the most common reason
for acute medical care in this population [30].
An emerging concern in nursing homes is
malnutrition, and a recent report describes the
role of oral health professionals in enhancing the
effects of nutritional interventions [31]. Oral
functional training for the maintenance and
improvement of feeding function enhances nutri-
tion among patients on a high-calorie or high-
protein diet. Thus, synergy between medical,
dental and nursing professionals would help to
prevent important medical complications with a
simple improvement in the oral hygiene pro-
grammes in long-term-care facilities and nursing
homes.
CONCLUSION
This brief review has given some examples to
highlight the importance of collaboration between
the medical and dental professions in order to
improve both oral and systemic health. Other
examples of medical conditions that would ben-
eﬁt from such a collaboration include human
immunodeﬁciency virus infection and AIDS, dia-
betes, rheumatoid arthritis, Sjo¨gren’s syndrome
and the status after organ transplantation.
Ongoing review of the curricula of medical
and dental schools should lead to better integra-
tion of the professions. Medical, dental and
nursing students should have the opportunity
to integrate as part of their training [32]. This
need has already been recognised in some US
and European medical schools, with the intro-
duction of oral health curricula in undergraduate
medical training [33]. Another need is the devel-
opment of a strong specialty in oral medicine
that would educate a professional capable of
serving as a partner to physicians [34]. Such
partnerships will contribute to the optimal man-
agement of patients who are ill as a result of the
emerging relationship between systemic and oral
conditions [33]. The outcomes of these collabo-
rations include decreased morbidity and mortal-
ity, and improved quality of life for ageing
populations around the world [31]. Education,
highlighting the importance of communications
between healthcare professionals, will lead to
better treatment options and enhance the level of
care [35].
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